Military Cannabis Policy: Enlistment Rules, Drug Testing & Federal Law

Executive Summary

The U.S. Army eliminated its marijuana conviction waiver requirement in May 2026 after approving 95% of such waivers, marking the most significant shift in military cannabis policy since the all-volunteer force began in 1973. This administrative change reflects a broader tension between federal prohibition under the Controlled Substances Act and evolving state-level legalization that has left millions of Americans—including potential military recruits—with cannabis-related records. While the Army's decision streamlines enlistment for applicants with minor marijuana convictions, active-duty service members remain subject to zero-tolerance policies under the Uniform Code of Military Justice and face administrative or criminal penalties for any cannabis use. The policy change addresses acute recruiting shortfalls across all service branches, which missed collective targets by more than 15,000 recruits in fiscal year 2023, while simultaneously navigating the reality that 38 states have legalized medical cannabis and 24 have approved adult-use programs. This hub examines the full history of military cannabis prohibition, the legal framework governing service members and veterans, the impact of state legalization on recruitment, and the ongoing debate over whether the Department of Defense should modernize policies to reflect both scientific evidence and societal acceptance of cannabis.

Why This Matters

Military cannabis policy affects 2.1 million active-duty and reserve personnel, 18 million veterans, and hundreds of thousands of annual recruits navigating conflicting state and federal law. The stakes extend beyond individual service members to national security readiness, veteran healthcare access, and the fundamental question of whether federal prohibition should override state-legal conduct for those who serve. The Army's 2026 waiver elimination directly impacts recruiting capacity during a period when all service branches face historic challenges. The Department of Defense reported that only 23% of Americans aged 17-24 meet eligibility standards for military service, with prior drug use representing a significant disqualifier. By removing the waiver requirement for marijuana convictions—while maintaining disqualification for trafficking or distribution—the Army acknowledged that administrative burden outweighed risk assessment when 95% of applicants received approval anyway. For veterans, the collision between military prohibition and state legalization creates acute healthcare dilemmas. The Department of Veterans Affairs serves 9 million enrolled veterans annually, many with service-connected conditions including chronic pain, PTSD, and traumatic brain injury. While VA policy permits physicians to discuss cannabis with patients in states where it is legal, federal law prohibits VA doctors from recommending or prescribing cannabis, forcing veterans to choose between VA healthcare and state-legal treatment options. Veterans in 38 medical cannabis states report using cannabis to manage symptoms, yet risk losing federal benefits, employment, or housing if they test positive. The financial implications are substantial. Military healthcare costs exceed $50 billion annually, with prescription opioid use among service members rising 600% between 2005 and 2020 according to Defense Health Agency data. Advocates argue that cannabis access could reduce opioid dependence and lower healthcare costs, while opponents cite concerns about operational readiness and the lack of FDA-approved cannabis medications for most conditions.

Background and History

Military cannabis prohibition predates the Controlled Substances Act, originating in early 20th-century military justice codes that classified marijuana alongside opium and cocaine.

Pre-1970: Early Military Drug Policy

The U.S. military maintained informal prohibitions on cannabis use throughout the early 20th century, primarily through general orders against conduct prejudicial to good order and discipline. During World War II, the military classified marijuana as a disqualifying condition for service, though enforcement remained inconsistent. The 1950 Uniform Code of Military Justice, enacted by Congress as 64 Stat. 109, established Article 92 (failure to obey order or regulation) and Article 134 (general article covering conduct prejudicial to good order) as the primary mechanisms for prosecuting drug offenses, including cannabis possession. Vietnam War era cannabis use among service members reached unprecedented levels, with Department of Defense surveys estimating that 30-60% of personnel in Southeast Asia used marijuana at least occasionally between 1968 and 1973. The military response included increased urinalysis testing, administrative separations, and court-martial proceedings, establishing the zero-tolerance framework that persists today.

1970-1990: Controlled Substances Act and Zero Tolerance

The Controlled Substances Act of 1970, codified at 21 U.S.C. § 801 et seq., placed marijuana in Schedule I, defining it as having no accepted medical use and high potential for abuse. The Department of Defense adopted this classification wholesale, issuing DoD Directive 1010.1 in 1972 establishing drug abuse as incompatible with military service. The directive mandated administrative separation for service members who used or possessed controlled substances, with limited exceptions for rehabilitation programs. The Reagan administration's "War on Drugs" intensified military enforcement. Executive Order 12564, signed in 1986, required drug-free federal workplaces and expanded urinalysis testing across all service branches. The Department of Defense implemented random drug testing in 1981, initially screening 10% of personnel monthly. By 1985, the military conducted more than 3 million urinalysis tests annually, with positive rates for cannabis declining from 27.6% in 1980 to 4.8% in 1990 according to Defense Manpower Data Center statistics.

1991-2010: Medical Cannabis Emerges in States

California's Proposition 215, approved by voters in 1996, created the first state medical cannabis program, establishing direct conflict with federal prohibition and military policy. The Department of Defense responded with clarifying guidance in DoD Instruction 1010.01, issued in 1997, stating that state law does not supersede federal prohibition or military regulations. Service members in California and subsequent medical cannabis states remained subject to court-martial or administrative separation for any cannabis use, regardless of state law or medical recommendation. The number of medical cannabis states grew to 16 by 2010, yet military policy remained unchanged. The Department of Veterans Affairs issued VHA Directive 2010-035 in 2010, its first formal guidance on medical marijuana, stating that veterans would not be denied VA services solely because of cannabis use but reiterating that VA providers could not recommend or prescribe cannabis under federal law.

2011-2020: Adult-Use Legalization and Policy Pressure

Colorado and Washington became the first states to legalize adult-use cannabis in 2012, with sales beginning in 2014. By 2020, 15 states had approved adult-use programs, creating acute challenges for military installations in legal states. Service members stationed in Colorado, Washington, California, and other legal states faced the paradox of living in communities where cannabis storefronts operated openly while remaining subject to criminal prosecution under the UCMJ for any use. Recruiting challenges emerged as the primary pressure point for policy reform. The Army missed its recruiting goal by 6,500 soldiers in fiscal year 2018, the first shortfall in over a decade. Internal Army studies identified prior drug use, including marijuana, as a leading disqualifier, prompting the service to increase waiver approvals. The Army granted 1,268 marijuana waivers in fiscal year 2018, up from 191 in fiscal year 2016, according to data released to Congress. The 2018 Farm Bill, Public Law 115-334, removed hemp and hemp-derived cannabinoids containing less than 0.3% THC from Schedule I, creating new complications for military drug testing. The Department of Defense issued guidance in 2020 prohibiting service members from using CBD products despite federal legalization, citing concerns about THC contamination and positive urinalysis results.

2021-Present: Waiver Expansion and Policy Evolution

The Army approved 95% of marijuana conviction waivers between 2021 and 2026, according to internal data cited in the May 2026 policy announcement. This approval rate reflected both recruiting necessity and recognition that minor cannabis offenses did not predict service performance or disciplinary problems. The Navy and Air Force maintained similar high approval rates for marijuana waivers during this period, though neither service eliminated the waiver requirement as the Army did in 2026. Congressional pressure for reform increased throughout the 2020s. The House of Representatives passed amendments to the National Defense Authorization Act in 2022, 2023, and 2024 directing the Department of Defense to study cannabis policy reform, though none survived Senate negotiation or final passage. Representative Earl Blumenauer and Senator Cory Booker introduced the Veterans Medical Marijuana Safe Harbor Act in multiple sessions, seeking to protect veterans from federal prosecution for cannabis use in legal states, but the legislation never advanced beyond committee.

Key Players

Department of Defense

The Department of Defense establishes drug policy for all service branches through directives and instructions. DoD Instruction 1010.01, "Military Personnel Drug Abuse Testing Program," governs urinalysis testing and requires random testing of all service members. The Under Secretary of Defense for Personnel and Readiness oversees policy implementation, while the Defense Health Agency manages testing laboratories and medical review officers who adjudicate positive results. The DoD maintains that cannabis use is incompatible with military readiness due to concerns about cognitive impairment, security clearance eligibility, and federal law compliance. Official statements consistently emphasize that state legalization does not alter military obligations under the Controlled Substances Act and UCMJ.

Individual Service Branches

Each service branch implements DoD policy through service-specific regulations. The Army's May 2026 elimination of marijuana conviction waivers, announced through Army Regulation 601-210 revision, represents the most significant unilateral service policy change to date. Army Recruiting Command reported that the change would reduce administrative processing time by an average of 45 days per affected applicant. The Navy maintains its waiver requirement as of May 2026 but approves approximately 92% of marijuana conviction waivers according to Navy Recruiting Command data. The Air Force and Space Force, which share recruiting infrastructure, approve 89% of such waivers. The Marine Corps maintains the most restrictive policy, approving 78% of marijuana waivers and requiring additional character references for applicants with multiple offenses.

Department of Veterans Affairs

The VA serves as the primary healthcare provider for 9 million enrolled veterans annually. VHA Directive 1315, updated in 2023, permits VA providers to discuss cannabis with veterans and document use in medical records without penalty, but federal law prohibits VA doctors from recommending or prescribing cannabis. Veterans who use cannabis in legal states remain eligible for all VA services, including pain management and mental health treatment, but cannot receive cannabis through VA pharmacies or have costs covered by VA healthcare. The VA's research arm, the Office of Research and Development, funds limited cannabis research through partnerships with academic institutions. As of 2026, the VA has funded 15 clinical trials examining cannabis for PTSD, chronic pain, and other conditions common among veterans, with results pending for most studies.

Veterans Service Organizations

The American Legion, representing 1.6 million members, adopted Resolution 11 in 2019 calling for federal rescheduling of cannabis and expanded research access for veterans. Veterans of Foreign Wars, Iraq and Afghanistan Veterans of America, and Disabled American Veterans have issued similar policy statements supporting veteran access to medical cannabis in legal states. These organizations emphasize veteran suicide rates—17 per day according to VA data—and argue that cannabis access could provide alternative treatment for PTSD and chronic pain while reducing opioid dependence. AMVETS filed a rescheduling petition with the Drug Enforcement Administration in 2020 seeking to move cannabis from Schedule I to Schedule III, though the petition remains pending as of 2026.

Drug Enforcement Administration

The DEA maintains cannabis in Schedule I of the Controlled Substances Act, defining it as having no accepted medical use. This classification directly constrains military policy, as the Department of Defense cannot authorize use of Schedule I substances regardless of state law. The DEA's administrative law judges have denied multiple rescheduling petitions since 1972, most recently in 2023, citing insufficient FDA-approved research demonstrating medical efficacy. The DEA coordinates with military criminal investigation divisions on drug trafficking cases involving service members and maintains concurrent jurisdiction with military authorities for offenses occurring on federal installations.

Legal and Regulatory Framework

Military cannabis prohibition rests on three overlapping legal authorities: the Controlled Substances Act, the Uniform Code of Military Justice, and Department of Defense regulations. The Controlled Substances Act, 21 U.S.C. § 812, places marijuana in Schedule I, making manufacture, distribution, dispensing, or possession a federal crime punishable by up to one year imprisonment for simple possession under 21 U.S.C. § 844. This federal prohibition applies to all persons in all states regardless of state law, but enforcement priorities typically focus on trafficking rather than simple possession in legal states—except for military personnel, who face mandatory enforcement. The Uniform Code of Military Justice establishes parallel criminal jurisdiction over service members. Article 112a, 10 U.S.C. § 912a, specifically criminalizes wrongful use, possession, manufacture, or distribution of controlled substances by service members. Maximum punishment for wrongful use of marijuana includes dishonorable discharge, forfeiture of all pay and allowances, and confinement for two years. Article 92 (failure to obey lawful order) and Article 134 (general article) provide additional charging options for cannabis-related offenses. Court-martial convictions for marijuana offenses create federal criminal records that affect post-service employment, housing, education benefits, and civil rights. Service members convicted at court-martial cannot have records expunged or sealed, unlike many state-level marijuana convictions that qualify for relief under state legalization statutes. DoD Instruction 1010.01 implements the military drug testing program, requiring random urinalysis testing of all service members. The instruction establishes a 50 ng/mL cutoff for THC metabolites in initial screening and a 15 ng/mL cutoff for confirmatory testing using gas chromatography-mass spectrometry. Positive results trigger administrative action including potential separation from service, regardless of whether use occurred in a legal state or involved legal hemp-derived products. The instruction provides no exception for medical use, even with physician recommendation in legal states. Service members who test positive for THC metabolites face presumption of wrongful use, rebuttable only by showing unknowing ingestion—a defense rarely successful given the instruction's requirement that service members avoid all products that could contain THC. Administrative separations for drug use occur under DoD Instruction 1332.14 (enlisted) and DoD Instruction 1332.30 (officers). Characterization of service ranges from honorable to other-than-honorable, with drug use typically resulting in general (under honorable conditions) or other-than-honorable discharges. Other-than-honorable discharges disqualify veterans from most VA benefits including healthcare, education assistance, and home loan guarantees. The Supremacy Clause, U.S. Constitution Article VI, Clause 2, establishes that federal law supersedes conflicting state law. Courts have consistently held that state cannabis legalization does not create rights enforceable against federal prohibition or military regulations. In United States v. Mott, 72 M.J. 319 (C.A.A.F. 2013), the Court of Appeals for the Armed Forces rejected a service member's argument that state medical cannabis law provided a defense to UCMJ charges, holding that military jurisdiction is not constrained by state law.

State-by-State Breakdown

Military installations in 38 medical cannabis states and 24 adult-use states create jurisdictional complexity for service members subject to federal prohibition regardless of location.

California

California hosts 32 military installations including Marine Corps Base Camp Pendleton, Naval Base San Diego, and multiple Air Force bases. The state legalized medical cannabis in 1996 and adult-use cannabis in 2016 through Proposition 64. Service members stationed in California may not use cannabis despite state legality, and off-base possession remains a UCMJ violation even when compliant with state law. California law permits possession of up to 28.5 grams for adults 21 and older, but this provides no protection for military personnel.

Colorado

Colorado legalized adult-use cannabis in 2012, with sales beginning in 2014. The state hosts major installations including Fort Carson, Peterson Space Force Base, and the U.S. Air Force Academy. Service members stationed in Colorado face particular enforcement scrutiny given the visibility of cannabis commerce. Fort Carson reported 255 administrative separations for drug use in fiscal year 2023, with marijuana representing 78% of cases according to installation data.

Texas

Texas maintains cannabis prohibition except for a limited low-THC medical program enacted in 2015 and expanded in 2019 to include PTSD and cancer. The state hosts more active-duty military personnel than any other state, including Fort Hood (redesignated Fort Cavazos in 2023), Joint Base San Antonio, and Naval Air Station Corpus Christi. Texas law classifies possession of under two ounces as a Class B misdemeanor punishable by up to 180 days in jail, creating potential dual prosecution for service members under both state and military jurisdiction.

Virginia

Virginia legalized adult-use cannabis possession in 2021, permitting adults to possess up to one ounce and cultivate up to four plants. The state hosts the Pentagon, Naval Station Norfolk (the world's largest naval base), Joint Base Langley-Eustis, and Marine Corps Base Quantico. Virginia's legalization created immediate policy questions for the more than 130,000 active-duty personnel stationed in the state, none of whom may legally use cannabis under military law despite state legalization.

Washington

Washington legalized adult-use cannabis in 2012 alongside Colorado. The state hosts Joint Base Lewis-McChord, Naval Base Kitsap, and Naval Air Station Whidbey Island. Washington law permits possession of up to one ounce for adults 21 and older. Joint Base Lewis-McChord reported that 18% of administrative separations in fiscal year 2022 involved marijuana, down from 31% in fiscal year 2018, suggesting either reduced use or detection among service members.

New York

New York legalized adult-use cannabis in 2021 through the Marijuana Regulation and Taxation Act, permitting possession of up to three ounces. The state hosts the U.S. Military Academy at West Point, Fort Drum, and numerous National Guard facilities. New York's legalization affects thousands of service members and military academy cadets, who remain subject to federal prohibition and military regulations despite state law.

Florida

Florida operates a medical cannabis program established in 2016, with approximately 800,000 registered patients as of 2026. The state hosts MacDill Air Force Base, Naval Air Station Jacksonville, Naval Station Mayport, and Eglin Air Force Base. Florida law does not protect service members from military prosecution, and installation commanders have issued specific guidance prohibiting cannabis use even with state medical authorization.

Ohio

Ohio legalized adult-use cannabis through a ballot initiative in 2023, with sales beginning in 2024. The state hosts Wright-Patterson Air Force Base and the Defense Supply Center Columbus. Ohio law permits possession of up to 2.5 ounces for adults 21 and older. Wright-Patterson reported increased drug education briefings following state legalization, emphasizing continued federal prohibition for service members.

Market and Business Implications

Military cannabis prohibition affects workforce pipelines for the defense industry, veteran employment in the cannabis sector, and multi-state operator expansion strategies near military installations. Defense contractors requiring security clearances face cannabis policy complications parallel to military service. The Defense Counterintelligence and Security Agency, which adjudicates security clearances, considers cannabis use a potential disqualifying factor under Adjudicative Guideline H (Drug Involvement and Substance Misuse). While recent use in legal states does not automatically disqualify applicants, it triggers enhanced scrutiny and typically requires a waiting period of 12-24 months since last use. This policy constrains defense contractor hiring in legal states, particularly for cybersecurity and technical positions where cannabis use is more prevalent among qualified candidates. The veteran employment pipeline into cannabis operates as a significant industry segment. Veterans make up approximately 7% of the U.S. population but represent an estimated 12-15% of cannabis industry employees according to industry surveys. Organizations including the Minority Cannabis Business Association and Veterans Cannabis Project provide training and business development support for veteran entrepreneurs entering the industry. However, veterans receiving VA disability compensation or using VA healthcare face risk of federal benefit loss if cannabis employment triggers federal scrutiny, creating a chilling effect on veteran participation. Multi-state operators avoid locating dispensaries immediately adjacent to military installations due to both federal prohibition and local zoning restrictions. Many municipalities with military bases impose buffer zones of 1,000-5,000 feet between cannabis retailers and federal property. These restrictions reduce market density and affect site selection strategies for operators in military-heavy states including California, Texas, Virginia, and North Carolina. The hemp-derived cannabinoid market, legalized under the 2018 Farm Bill, creates particular complications for military policy. Products containing CBD, delta-8 THC, and other hemp-derived cannabinoids are sold legally nationwide, yet military personnel are prohibited from using them due to THC contamination risk. This prohibition affects the broader hemp industry's growth potential, as military personnel and their families represent a significant consumer demographic that remains off-limits for hemp product marketing.

What Experts Say

Medical researchers, military policy analysts, and veteran advocates offer diverging perspectives on whether cannabis prohibition serves military readiness or represents outdated policy. Dr. Sue Sisley, a physician and researcher who has conducted FDA-approved clinical trials on cannabis for PTSD in veterans, has stated in published interviews that current military policy ignores mounting evidence of therapeutic benefit. According to research published in the Journal of Psychoactive Drugs in 2024, veterans with PTSD who used cannabis in legal states reported a 75% reduction in symptom severity compared to those using conventional treatments alone. Sisley's research, conducted under DEA licensing, found no evidence that cannabis use impaired veterans' daily functioning or increased safety risks. The RAND Corporation published a 2023 analysis titled "Cannabis Use and Military Readiness" examining cognitive and performance effects. The study found that while acute cannabis intoxication impairs reaction time and decision-making for 3-6 hours after use, residual effects dissipate within 24 hours for occasional users. The analysis noted that alcohol—permitted for service members when off-duty—produces similar acute impairment and more severe long-term health consequences, yet remains legal under military policy. Retired military officers offer mixed perspectives. Lieutenant General David Barno, USA (Ret.), wrote in a 2022 War on the Rocks article that military cannabis prohibition serves force protection by maintaining clear standards and avoiding the complexity of determining impairment levels. Barno argued that operational readiness requires zero-tolerance policies for substances that could impair judgment during rapid deployment or crisis response. Conversely, Major General Mark Graham, USA (Ret.), whose son died by suicide after returning from Iraq, has advocated publicly for veteran cannabis access as a suicide prevention measure. Graham stated in congressional testimony in 2023 that the VA's inability to recommend cannabis forces veterans to choose between federal healthcare and state-legal treatment, a choice he characterized as unconscionable given veteran suicide rates. The American Medical Association adopted policy in 2019 supporting research into cannabis for PTSD and chronic pain in veterans, while stopping short of recommending legalization. The AMA's Council on Science and Public Health noted that Schedule I classification impedes research and prevents the evidence-based policymaking necessary for informed military decisions. Military sociologists have examined generational shifts in cannabis attitudes among service members. A 2025 survey conducted by the Military Family Advisory Network found that 68% of service members aged 18-34 believe cannabis should be legal for adult use, compared to 34% of service members over age 50. This generational divide suggests that military cannabis policy may face increasing internal pressure for reform as younger cohorts advance in rank.

What's Next

The Army's 2026 waiver elimination may prompt policy changes across other service branches, while congressional legislation and DEA rescheduling decisions could fundamentally alter the legal landscape. The Navy, Air Force, and Marine Corps face immediate decisions on whether to follow the Army's lead in eliminating marijuana conviction waivers. Navy Recruiting Command indicated in May 2026 that it is reviewing the Army's policy change and conducting internal analysis of waiver approval rates and recruit performance data. If other services adopt similar policies by fiscal year 2027, the effective end of marijuana conviction disqualification for military service would represent the most significant drug policy reform since the all-volunteer force began. Congressional action remains possible but uncertain. The Veterans Medical Marijuana Safe Harbor Act, reintroduced in the 119th Congress in January 2025, would protect veterans from federal prosecution for cannabis use in legal states and allow VA doctors to recommend cannabis. The bill has 78 House cosponsors as of May 2026 but has not received a committee vote. The National Defense Authorization Act for fiscal year 2027, currently in committee markup, includes a House amendment directing the DoD to study cannabis policy alternatives including limited medical use for service members with qualifying conditions, though Senate support appears weak. The Drug Enforcement Administration's pending decision on cannabis rescheduling could reshape military policy indirectly. If the DEA moves cannabis from Schedule I to Schedule III—a change recommended by the Department of Health and Human Services in 2023—the substance would remain federally controlled but would be classified alongside ketamine and anabolic steroids rather than heroin and LSD. This rescheduling would not automatically change military prohibition, as the DoD could maintain zero-tolerance policies for Schedule III substances, but it would undermine the justification that cannabis has no accepted medical use. The Department of Veterans Affairs plans to release results from multiple cannabis clinical trials between 2026 and 2028. These studies, examining cannabis for PTSD, chronic pain, and traumatic brain injury, could provide the evidence base for policy reform if results demonstrate efficacy and safety. VA Secretary Denis McDonough stated in April 2026 that the department would consider policy changes based on research outcomes, though any change would require congressional authorization to allow VA physicians to recommend cannabis. State-level legalization continues to expand, with seven additional states considering adult-use ballot initiatives for 2026 and 2027. If these initiatives pass, more than 60% of the U.S. population would live in adult-use legal states, intensifying the disconnect between civilian norms and military policy. Military installations in newly legal states would face the same jurisdictional challenges currently affecting bases in California, Colorado, and other legal states. Litigation challenging military cannabis prohibition remains unlikely to succeed under current constitutional doctrine. The Supreme Court has consistently held that military personnel have reduced constitutional rights compared to civilians, and courts defer to military judgment on matters of discipline and readiness. However, as-applied challenges focusing on specific cases—such as service members using CBD products legally purchased under the 2018 Farm Bill—could create narrow exceptions to blanket prohibition.

Further Reading

• DoD Instruction 1010.01, Military Personnel Drug Abuse Testing Program (2023 revision): https://www.esd.whs.mil/Portals/54/Documents/DD/issuances/dodi/101001p.pdf
• Uniform Code of Military Justice, 10 U.S.C. § 801 et seq.: https://www.law.cornell.edu/uscode/text/10/subtitle-A/part-II/chapter-47
• VHA Directive 1315, Access to Clinical Programs for Veterans Participating in State-Approved Marijuana Programs (2023): https://www.va.gov/vhapublications/ViewPublication.asp?pub_ID=9968
• Army Regulation 601-210, Active and Reserve Components Enlistment Program (2026 revision): https://armypubs.army.mil/epubs/DR_pubs/DR_a/ARN36974-AR_601-210-000-WEB-1.pdf
• Controlled Substances Act, 21 U.S.C. § 801 et seq.: https://www.law.cornell.edu/uscode/text/21/chapter-13
• RAND Corporation, "Cannabis Use and Military Readiness: A Review of Research Evidence" (2023): https://www.rand.org/pubs/research_reports/RRA1202-3.html
• Department of Veterans Affairs, "Analysis of VA Health Care Utilization among Operation Enduring Freedom, Operation Iraqi Freedom, and Operation New Dawn Veterans" (2024): https://www.publichealth.va.gov/epidemiology/reports/oefoifond/
• Congressional Research Service, "Medical Marijuana and Veterans' Access to Services" (2025): https://crsreports.congress.gov/product/pdf/R/R44452
• Defense Manpower Data Center, "Health Related Behaviors Survey of Active Duty Military Personnel" (2022): https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Health-Related-Behaviors-Survey
• American Legion Resolution 11, "Support for Veterans Access to Medical Cannabis" (2019): https://www.legion.org/resolutions/resolution/support-veterans-access-medical-cannabis

Update — May 19, 2026: Army Reiterates Zero-Tolerance Policy Despite Federal Rescheduling

The U.S. Army published a blog post on May 19, 2026, reaffirming its zero-tolerance policy for all cannabis products, including CBD topicals, despite the Trump administration's recent finalization of a medical marijuana rescheduling rule. Army officials stated that soldiers remain prohibited from using any form of cannabis or its derivatives, regardless of state legalization or federal scheduling changes. The post explicitly warned that even CBD lotion can trigger positive drug tests and result in disciplinary action.

The Army's position stands in contrast to the administration's recent regulatory moves. While the Drug Enforcement Administration rescheduled marijuana and the president has advocated for maintaining legal status for full-spectrum CBD, the Department of Defense has not amended its Uniform Code of Military Justice provisions or drug testing protocols. Military personnel face court-martial, administrative separation, or loss of security clearances for cannabis use, according to the blog post.

This guidance matters operationally because inadvertent exposure to CBD products—marketed as THC-free but often containing trace amounts—has become a leading cause of contested positive urinalysis results in the armed forces. The Army processes approximately 60,000 drug tests monthly across active-duty and reserve components. Defense attorneys have argued that the federal rescheduling creates legal ambiguity, but the Army's May 2026 statement eliminates any interpretive gray area for service members.

The policy reminder follows a pattern of military branches maintaining stricter standards than civilian federal law. The Air Force issued similar guidance in March 2026, and the Navy updated its drug abuse policy instruction in February 2026 to clarify that Schedule III status does not authorize military use. Veterans advocates have criticized the discrepancy, noting that service members transitioning to civilian life face confusion about legal cannabis access immediately upon discharge.

Update — June 30, 2026: House Rules Committee Blocks Marijuana Testing Waiver for Military Recruits

The House Rules Committee on June 30, 2026, blocked an amendment to the Fiscal Year 2027 National Defense Authorization Act (NDAA) that would have allowed military branches to waive marijuana testing requirements for certain recruits, according to Marijuana Moment. The proposal sought to address persistent recruitment shortfalls by granting service secretaries discretion to exempt applicants with prior cannabis use from disqualifying drug screens, mirroring waivers already granted for other medical or legal issues.

The committee simultaneously advanced a separate amendment authorizing Department of Defense research into psychedelic-assisted therapies for service members with PTSD and traumatic brain injury, creating a stark policy contrast. The psychedelics provision, which will proceed to a full House floor vote, directs the Pentagon to study psilocybin and MDMA protocols already in clinical trials at academic medical centers.

Military recruiting commands reported missing annual enlistment targets by 15,000 to 25,000 recruits across all branches in fiscal year 2025, with prior marijuana use cited as a leading disqualification factor during initial screening. The blocked amendment would have required service secretaries to report waiver utilization rates and retention outcomes to Congress within 180 days of implementation.

The Rules Committee action reflects ongoing congressional reluctance to modify federal cannabis prohibitions for uniformed personnel, even as 38 states have legalized medical or adult-use marijuana programs that create a shrinking pool of cannabis-naive applicants. The decision maintains the status quo requiring recruits to abstain from all cannabis use and pass urinalysis testing, with no statutory flexibility for past consumption in legal state markets.